Fingerprint Dive into the research topics where Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Antineoplastic Combined Chemotherapy Protocols Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2019

A phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas

Philip, P. A., Buyse, M. E., Alistar, A. T., Lima, C. M., Luther, S., Pardee, T. S. & Cutsem, E. V., Jan 1 2019, In : Future Oncology. 15, 28, p. 3189-3196 8 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Pancreas
Adenocarcinoma
Carbon
Ketoglutarate Dehydrogenase Complex
1 Citation (Scopus)

CT screening for lung cancer: comparison of three baseline screening protocols

Writing Committee for the I-ELCAP Investigators, Oct 1 2019, In : European Radiology. 29, 10, p. 5217-5226 10 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Biopsy
Early Detection of Cancer
Costs and Cost Analysis
Growth
6 Citations (Scopus)
Multiple Myeloma
Dexamethasone
United States Food and Drug Administration
Disease-Free Survival
Stevens-Johnson Syndrome

Press/Media

Morristown Women in Business Hosts Pioneer in Pancreatic Cancer Research

Angela Alistar

11/30/19

1 item of Media coverage

Press/Media: Press / Media

Morristown Women in Business Host Dr. Angela Alistar, a Pioneer in Pancreatic Cancer Research

Angela Alistar

11/27/1911/29/19

2 items of Media coverage

Press/Media: Press / Media

Local Women in Business Host Pioneer in Pancreatic Cancer Research

Angela Alistar

11/27/19

1 item of Media coverage

Press/Media: Press / Media